W Kyle Simmons

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Bipolar Disorder

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Nature medicine

Molecular psychiatry

Oklahoma State University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oklahoma State University Jan 31 2020

United States

Associate Professor :: Pharmacology and Physiology

University of Tulsa Jan 01 2012

United States

Assistant Professor :: Faculty of Community Medicine

Laureate Institute for Brain Research Aug 01 2009

United States

Assistant Professor

Publications

Lorenzo Leggio, Christian S Hendershot, Mehdi Farokhnia, Anders Fink-Jensen, Mette Kruse Klausen, Joseph P Schacht, W Kyle Simmons
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders. Nature medicine (2023)
Mark E Schmidt, Michael R Liebowitz, Murray B Stein, Jennifer Grunfeld, Ilse Van Hove, W Kyle Simmons, Peter Van Der Ark, James A Palmer, Ziad S Saad, Darrel J Pemberton, Luc Van Nueten, Wayne C Drevets
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (5) (2020)
Yuri Milaneschi, W Kyle Simmons, Elisabeth F C van Rossum, Brenda Wjh Penninx
Depression and obesity: evidence of shared biological mechanisms. Molecular psychiatry 24 (1) (2018)